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Introduction: Chondrocytes rely primarily on glycolysis to meet cellular energy needs, but recent studies implicate
impaired mitochondrial function in osteoarthritis (OA) pathogenesis. Our objectives were to investigate the ability
of chondrocytes to upregulate mitochondrial respiration when challenged with a nutrient stress and determine the
effect on mediators of chondrocyte oxidative homeostasis.
Methods: Primary bovine chondrocytes were isolated and cultured in alginate beads. Mitochondrial respiration was
stimulated by culturing cells with galactose-supplemented media for a period of 1 or 5 days. Metabolic flexibility
was assessed by measuring metabolite and enzymatic biomarkers of glycolytic and mitochondrial metabolism.
Oxidative homeostasis was assessed by measuring (1) cellular glutathione content and redox homeostasis, (2) rates
of nitric oxide and superoxide production, and (3) the abundance and activity of cellular anti-oxidant proteins,
especially the mitochondrial isoform of superoxide dismutase (SOD2). The regulatory role of hypoxia-inducible factor
2α (HIF-2α) in mediating the metabolic and redox responses was evaluated by chemical stabilization with cobalt
chloride (CoCl2).
Results: After 5 days of galactose culture, lactate production and lactate dehydrogenase activity were reduced by
92% (P <0.0001) and 28% (P = 0.051), respectively. Conversely, basal oxygen consumption increased 35% (P = 0.042)
without increasing mitochondrial content. Glutathione redox homeostasis was unaffected by galactose culture.
However, the production of nitric oxide and superoxide and the expression and activity of SOD2 were significantly
reduced after 5 days in galactose culture. Nuclear protein expression and gene expression of HIF-2α, a transcription
factor for SOD2, were significantly downregulated (more than twofold; P <0.05) with galactose culture. CoCl2-mediated
stabilization of HIF-2α during the initial galactose response phase attenuated the reduction in SOD2 (P = 0.028) and
increased cell death (P = 0.003).
Conclusions: Chondrocyte metabolic flexibility promotes cell survival during a nutrient stress by upregulating
mitochondrial respiration and reducing the rate of reactive nitrogen and oxygen species production. These
changes are coupled to a substantial reduction in the expression and activity of the mitochondrial anti-oxidant
SOD2 and its pro-catabolic transcription factor HIF-2α, suggesting that an improved understanding of physiologic
triggers of chondrocyte metabolic flexibility may provide new insight into the etiology of OA.* Correspondence: tim-griffin@omrf.org
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The avascular environment of articular cartilage is gen-
erally thought to restrict chondrocyte metabolism to
relatively low rates of anaerobic glycolysis due to limits
in the rate of oxygen and nutrient diffusion from the
synovial fluid, particularly in the middle and deep cartilage
zones [1-3]. In addition, the relatively low mitochondrial
content and slow rates of respiration in chondrocytes may
be considered adaptive for minimizing oxidative damage
in long-lived post-mitotic cells [4]. These metabolic char-
acteristics, however, do not appear to be wholly derived
from the unique avascular cartilage environment and slow
turnover of cells as they are also shared by mesenchymal
stem cells (MSCs) [5]. MSCs are resistant to exposure to
hypoxia or inhibition of mitochondrial respiration due to
the strong reliance on anaerobic glycolysis for ATP pro-
duction [5]. Thus, unlike many cells derived from MSCs
that upregulate mitochondrial respiration during differen-
tiation, chondrocytes appear to maintain a more undiffer-
entiated MSC-like metabolic state [6].
The strong reliance on anaerobic glycolysis as the pri-
mary ATP-producing pathway of cartilage raises questions
about the metabolic role of mitochondria in chondrocytes
[7,8]. Mitochondrial respiration is not limited by oxygen
availability, because even at normoxic oxygen concentra-
tions chondrocytes continue to primarily use glycolysis for
ATP production [8-10]. However, under anoxic condi-
tions, chondrocytes reduce the rate of anaerobic glycolysis,
demonstrating a negative Pasteur effect [10]. Recent stud-
ies suggest that the rate of glycolysis is dependent on at
least a minimal flux of oxygen through the mitochondrial
respiratory chain (MRC) to activate or stabilize glycolytic
enzymes through MRC-derived reactive oxygen species
(ROS) [11]. A better understanding of the relationship be-
tween chondrocyte metabolism and ROS production will
help elucidate the functional role of mitochondria in
chondrocyte metabolism and may provide insight into
how mitochondrial dysfunction contributes to osteoarth-
ritis (OA) disease pathology.
OA cartilage is characterized by multiple forms of oxi-
dative modifications to lipids, proteins, and nucleic acids
[12,13]. Impaired MRC activity is implicated as a source
of pathologic ROS production leading to oxidative stress
in OA [8,14,15]. In healthy cartilage, pro-inflammatory
cytokines and nitric oxide inhibit the activity of com-
plexes I and IV of the MRC, respectively, suggesting that
increased mitochondrial-ROS production is a downstream
consequence of cellular inflammation [16-18]. In addition
to increased ROS production, mitochondria may be more
susceptible to ROS damage with OA due to an impaired
anti-oxidant system. In particular, SOD2, the mitochon-
drial isoform of superoxide dismutase, is downregulated in
OA cartilage [8,19-21]. When SOD2 is silenced in healthy
chondrocytes, cells accumulate malondialdehyde, a lipidperoxidation product [8]. In addition, mitochondria respire
closer to their maximal capacity and increase mitochon-
drial proton leak [8]. This suggests that changes in the
mitochondrial redox balance regulate mitochondrial respir-
ation and perhaps overall cellular metabolism. Therefore, a
better understanding of the relationship between cellular
redox and metabolic flexibility in healthy chondrocytes
may generate new insight into the role of altered metabol-
ism in the pathogenesis of OA.
There were two goals of this study. First, we wanted to
determine the capacity and mechanisms by which chon-
drocytes upregulate mitochondrial respiration in response
to a nutrient stress. Mitochondrial metabolism is an effi-
cient means of producing ATP when metabolic substrates
are limiting, and under growth or repair conditions, insuf-
ficient MRC activity may lead to a depletion of cellular
ATP levels [22]. Second, we wanted to determine the ef-
fect of upregulating MRC activity on chondrocyte redox
balance. Chondrocyte metabolism undergoes dynamic
changes in response to inflammatory and mechanical
stressors [23-27]. Understanding how chondrocyte redox
homeostasis is affected during changes in cellular metab-
olism independent of these additional stressors is import-
ant for identifying potential metabolic origins of oxidative
stress in OA.
We stimulated chondrocyte MRC activity by replacing
glucose with galactose in the cell culture media of healthy
primary bovine chondrocytes. Galactose creates a nutrient
stress by requiring additional energy to convert to glucose.
In mammalian cells, replacing glucose with galactose as
the sole sugar source in the culture media is an effective
strategy for stimulating mitochondrial oxidative phosphor-
ylation and evaluating mitochondrial disorders and drug
toxicity [28-30]. Here, we show how a galactose-induced
metabolic stress stimulates chondrocyte MRC activity and
impacts mitochondrial redox regulation.
Methods
Cell culture
Bovine fetlock joints were purchased from a local slaugh-
terhouse in accordance with a protocol approved from the
Oklahoma Medical Research Foundation (OMRF) Institu-
tional Animal Care and Use Committee. Joints were
cleaned and cartilage was extracted for cellular isolation
within 8 hours of death. Cartilage was incubated in 1,320
U Pronase (Calbiochem from EMD Millipore, Billerica,
MA, USA) per mL low glucose Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with kanamycin
(100 μg/mL), gentamycin (150 μg/mL), non-essential amino
acids, HEPES (10 mM), 5% fetal bovine serum, and
penicillin-streptomycin (50 U/mL) for 1 hour (Gibco
brand media reagents from Life Technologies, Carlsbad,
CA, USA). Pronase-enriched media was then replaced
with 0.3% collagenase, type 2 (Worthington Biochemical
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culture media containing non-essential amino acids,
HEPES (10 mM), 5% fetal bovine serum, and 100 U/mL
penicillin-streptomycin and incubated overnight. Cells
were strained through a 70-μm filter, counted, and
assessed for viability by using trypan blue exclusion and
a Cellometer AutoT4 cell counter (Nexcelom Bioscience,
Lawrence, MA, USA). Finally, cells were re-suspeneded in
2.0% alginate 150 mM sodium chloride solution (pH 7.4)
at 4 × 106 cells/mL. The cell solution was carefully pipet-
ted into a 102 mM calcium chloride solution (pH 7.4) to
encapsulate the cells in alginate beads. Beads were cul-
tured in 6 mM glucose culture media or no-glucose, no
pyruvate culture media enriched with 6 mM galactose for
a period of up to 5 days. For 1-day galactose experiments,
cells were maintained in glucose-supplemented media for
4 to 5 days prior to replacing with fresh glucose or galact-
ose media, thereby minimizing differences in total culture
duration. To compare the difference between galactose
treatment and glycolysis inhibition on cell viability, we
also cultured cells in 6 mM 2-deoxy-D-glucose (Sigma-
Aldrich, St. Louis, MO, USA), a glucose analog that in-
hibits glycolysis. To quantify HIF-2α nuclear expression,
200 μM cobalt chloride (CoCl2) (ACROS Organics from
Thermo Fisher Scientific, Waltham, MA, USA) was
added to the media 1 day prior to harvest [31]. Cells were
digested out of alginate with 55 mM sodium citrate (pH 6)
and tested for viability as previously described.
Cells were re-suspended in the following concentra-
tions and buffers according to the following analyses: (1)
cell respiration: 2 × 106 cells/mL phosphate-buffered sa-
line (PBS) (pH 7.4); (2) enzyme activity: 106 cells/mL
1.0 mM MOPS/10 mM EDTA (pH 7.4); (3) mRNA
quantification: 107 cells/mL TRIzol; and (4) Western
blot: 107 cells/mL RIPA with 0.1% NP40 (pH 7.4). Pro-
tein concentration for cell lysates was quantified by
using the Pierce BCA protein assay (Thermo Fisher
Scientific).
Cell respiration and mitochondrial staining
Chondrocyte respiration was measured by using a Clark-
style oxygen electrode (Instech, Plymouth Meeting, PA,
USA) in a temperature-regulated chamber set to 37°C
(Hansatech Instruments Ltd, Norfolk, UK). The starting
amount of molecular oxygen in the 0.6-mL electrode
chamber was based on the assumption that 213 nmol/mL
of molecular oxygen is dissolved at atmospheric pressure
and 37°C. Basal respiration was measured as the average
rate of unstimulated oxygen consumption. Maximal respir-
ation was determined after stimulation with 0.8 μM FCCP,
an electron transport chain uncoupler. Mitochondrial-
specific oxygen consumption was determined by addition
of cyanide. To evaluate mitochondrial content, cells were
stained with Mitotracker Green FM (Molecular Probesfrom Life Technologies) and fluorescent intensity was
measured by using a FACSCalibur flow cytometer (BD
Biosciences, San Jose, CA, USA). Data were analyzed by
comparing the mean fluorescent intensity of glucose
versus galactose-cultured cells by using FlowJo software.
We also assessed mitochondrial content by using se-
lected reaction monitoring (SRM) mass spectrometry to
quantify the abundance of two mitochondrial reference
proteins, ATP5B and VDAC1, as described in detail fur-
ther below.Metabolic and redox biomarkers and enzymatic activities
Lactate dehydrogenase activity
Lactate dehydrogenase (LDH) activity was measured spec-
trophotometrically as the rotenone-independent oxidation
of 205 μM NADH to NAD+ (Agilent 8452A; Agilent
Technologies, Santa Clara, CA, USA) by monitoring the
decrease in A340nm in the presence of 10 μg protein and
1.5 mM pyruvate (Sigma-Aldrich) in 25 mM MOPS buf-
fer (pH 7.4). Activity was determined to be LDH specific
by using 25 mM of the competitive inhibitor, oxamate
(Sigma-Aldrich).Superoxide dismutase activity
Total (tSOD) and manganese-specific (SOD2) SOD ac-
tivity was determined spectrophotometrically (Sunrise™;
Tecan US, Morrisville, NC, USA) in accordance with the
instructions of the manufacturer (Cayman Chemicals
Company, Ann Arbor, MI, USA).Glucose and lactate measurement
Conditioned media was collected for measurement of
glucose and lactate concentration by using a YSI 2300
STAT Plus Glucose and Lactate Analyzer (Yellow Springs
Instruments, Yellow Springs, OH, USA). Conditioned
media samples were standardized to plate-matched non-
conditioned media blanks.Nitric oxide measurement
Total nitrate and nitrite (NOx) secretion into the media
was measured by using the Greiss reaction as previously
described [32].Glutathione assessment
Oxidized and reduced glutathione were measured spec-
trophotometrically (Tecan US) by using an enzymatic
recycling method to quantify the production of 5-thio-
2-nitrobenzoic acid (TNB) generated from the reaction
of reduced glutathione (GSH) with 5′-5′ dithio-bis-2 (nitro-
benzoic acid) (DTNB) in accordance with the instructions
of the manufacturer (Cayman Chemicals Company).
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The intracellular ratio of NAD+ to NADH in cell lysates
was measured by using an enzyme recycling reaction to
quantitate NADH absorbance in accordance with the in-
structions of the manufacturer (BioVision, Inc., Milpitas,
CA, USA).Energy charge
High-performance liquid chromatography (Shimadzu LC-
20A High Precision Binary Gradient HPLC system;
Shimadzu, Kyoto, Japan) and a UV/VIS diode array
spectrometer were used to resolve and detect AMP,
ADP, and ATP. The mobile phase consisted of 100 mM
KH2PO4 and 1.0 mM tetrabutylammonium sulfate (TBAS)
at pH 6.0 (buffer A) and CH3CN (buffer B) with a flow
rate of 1.0 mL/minute over an Eclipse Plus C18 column
with 5 μM diameter beads, 4.6 × 150 mM in length (Agi-
lent Technologies). Adenylate nucleotides were separated
by using the following step-wise gradients of buffer A/B:
96%/4% for 5 minutes, 85%/15% for 10 minutes, and 96%/
4% for 5 minutes. Concentrations of ATP, ADP, and AMP
were detected by absorption at 254 nm and quantified on
the basis of the integrated area of standards. Energy charge
was calculated by using the equation: ([ATP] + 0.5[ADP])/
([ATP] + [ADP] + [AMP]).Cellular free radical production
Superoxide production was assessed by electron para-
magnetic resonance (EPR) spin-trapping using a cyclic
hydroxylamine, CMH (1-hydroxy-3-methoxycarbonyl-
2,2,5,5-tetramethylpyrrolidine) [33]. Chondrocytes were
isolated as previously described and cultured in mono-
layer for 3 days in glucose-supplemented culture media
at 4.0 × 104 cells per well in a 48-well plate. Culture media
were then replaced with either glucose- or galactose-
supplemented DMEM culture media for 24 hours. After
washing with PBS, adherent cells were incubated with
500 μM CMH in the presence of 1 mM EDTA and 50 μM
DTPA in PBS at 37°C for 15 minutes. Reacted spin-traps
were immediately snap-frozen in LN2 after the incubation
period until the EPR measurement. High-density mono-
layer culture was required in place of alginate bead
culture to improve the rapid intra- and extra-cellular
equilibration of the spin-trap and thereby maximize the
signal to noise ratio.
The EPR spectra were obtained by using a Bruker EMX
spectrometer (Bruker Corporation, Billerica, MA, USA)
operating at X-band (approximately 9.78 GHz) with a
100 kHz modulation frequency and ER 41225SHQ high-
sensitivity cavity. Typical settings for the spectrometer are
microwave power, 6.325 mW; modulation amplitude,
1.5 G; scan range, 50 G; time constant, 82 ms. Thawed
sample mixtures were transferred immediately to a quartzflat-cell for the EPR determination. All of the EPR experi-
ments were performed at room temperature.RNA extraction, reverse transcription, and quantitative
real-time polymerase chain reaction
Immediately after chondrocyte digestion from alginate
beads, RNA was stabilized by using TRIzol in accord-
ance with the instructions of the manufacturer (Life
Technologies). A Qiagen First Strand cDNA kit (Qiagen,
Hilden, Germany) was used to convert mRNA to cDNA
in accordance with the instructions of the manufacturer.
Primers for EPAS1, SOD2, SOD1, CAT, COL2, NOS2,
ACAN, PTGS2, MMP13, ADAMTS4, HIF1, TFAM,
PGC1A, RLPLO, GAPDH, B-Actin, and B2M were pur-
chased from Qiagen’s validated RT2 qPCR Primer Assays
to quantify gene expression. A Bio-Rad CFX96 Real-Time
Detection system (Bio-Rad Laboratories, Hercules, CA,
USA) was used for amplification and quantification of
amplicons. Target genes were standardized to the
geometric mean of four housekeeping genes (RLPLO,
GAPDH, B-Actin, and B2M). Results were expressed as
standardized gene expression (2−ΔCt) or gene expression
of the galactose-treated sample normalized to the animal-
matched glucose control.Protein extraction and Western blot analysis
Cell lysates were centrifuged at 14,000 g for 10 minutes
to separate cytosolic and nuclear proteins. The nucleic
fraction was re-suspended in SDS running buffer, soni-
cated, and centrifuged again at 14,000 g for 10 minutes
for further clarification. Protein concentrations were de-
termined by Bradford assay and equalized between con-
ditions, separated on a 4% to 12% NuPAGE Bis-Tris gels
(Life Technologies), and transferred onto a polyvinyli-
dene difluoride (PVDF) or nitrocellulose membranes.
The following proteins were detected by using experi-
mentally determined antibody concentrations: succinate
dehydrogenase subunit A (SDHA) (1:500; Santa Cruz
Biotechnology, Inc., Dallas, TX, USA), superoxide dismut-
ase 1 (SOD1, 1:10,000; Santa Cruz Biotechnology, Inc.),
superoxide dismutase 2 (SOD2) (1:10,000, Santa Cruz Bio-
technology, Inc.), hypoxia-inducible factor-2alpha (HIF-
2α) (1:500; LifeSpan BioSciences, Inc., Seattle, WA, USA),
Lamin B1 (1:1,000; Santa Cruz Biotechnology, Inc.), and
actin conjugated to horseradish peroxidase (actin-HRP)
(1:3,000; Santa Cruz Biotechnology, Inc.). Expression was
quantified by using ImageJ software. To minimize the
contribution of inter-animal variation to reported out-
comes, glucose and galactose protein expression densities
were normalized to the total density on an animal-to-
animal basis and then averaged between animals. Proteins
of interest were standardized to Actin or Lamin B1 for
extra-nuclear and nuclear proteins, respectively.
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SRM mass spectrometry was used to quantify anti-oxidant
protein expression as previously described [34]. Briefly, 3
pmol of equine serum albumin (ESA) was added to each
20-μg sample of chondrocyte protein as an internal stand-
ard. The mixture was precipitated by acetone and sus-
pended in Laemmli loading buffer. Samples were run in
an SDS-PAGE gel to a distance of 1.5 cm. The entire lane
was cut for each sample and divided into 1-mm3 pieces,
reduced with DTT, alkylated with iodoacetamide, and
digested with trypsin. The peptides produced were ex-
tracted from the gel by 50% methanol with 10% formic
acid. The extract was evaporated to dryness and dissolved
in 150 μL of 1% acetic acid for analysis. Samples were
analyzed by using a TSQ Vantage triple quadrupole
mass spectrometer (Thermo Fisher Scientific), operated
in the SRM mode with a splitless nanoflow HPLC sys-
tem (Eksigent, Dublin, CA, USA). Samples (10 μL) were
injected onto a 10 cm × 75 μm C18 capillary column.
Data were processed by using Pinpoint to find and inte-
grate the correct peptide chromatographic peaks. To
quantify protein expression, the relative abundance of
each protein was first normalized to the ESA internal
standard and then normalized to the geometric mean of
four stable cellular reference proteins: glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), peptidyl-prolyl
isomerase A (PPIA), ribosomal protein S27a (RPS27A),
and vimentin (VIM).
Statistical analyses
Statistical significance of galactose or CoCl2 treatment
was determined by paired two- or one-tailed Student’s t
tests, as appropriate. The effect of culture duration in
addition to galactose treatment was determined by using
a two-way analysis of variance with repeated measures
for animal matching and Holm-Sidak’s multiple compar-
isons post hoc analysis. Significance was determined as a
P value of less than 0.05. Analyses were carried out by
using Prism 6 (GraphPad Software Inc., San Diego, CA,
USA). Results are reported as the mean ± standard error
of the mean for at least three individual animals as spe-
cified in the figure legends.
Results
Effect of galactose culture on chondrocyte metabolism
Culturing chondrocytes in either glucose- or galactose-
supplemented media for 1 or 5 days did not alter cell
viability (Figure 1A). However, galactose culture did sig-
nificantly alter chondrocyte metabolism. After 1 day in
galactose culture, lactate production decreased 54%,
from 17.3 to 8.0 μmol per 106 cells (P <0.0001). After
5 days of galactose culture, both lactate production and
maximal LDH activity were substantially reduced. Lactate
production decreased by 92% (P <0.0001; Figure 1B), andLDH activity was reduced by 28% (P = 0.051; Figure 1C).
These results are consistent with a substantial reduction
in glycolytic flux and a reduced reliance on glycolysis for
cellular ATP production. Galactose treatment, however,
was not equivalent to complete glycolytic inhibition. Cul-
turing chondrocytes for 1 day in 2-deoxy-D-glucose, a glu-
cose analog that inhibits glycolysis, caused a modest 8%
increase in cell death compared with galactose culture.
Chondrocytes responded to the galactose-induced re-
duction in glycolytic flux by increasing mitochondrial
respiration. After 1 day in galactose culture, basal oxy-
gen consumption increased 16% (P = 0.24), and by 5 days,
basal oxygen consumption increased 40% (P = 0.042;
Figure 1D). The increase in oxygen consumption with
galactose culture was associated with a trend for cells re-
spiring at a higher percentage of their maximal capacity
compared with glucose-cultured cells (P = 0.10; Figure 1E).
Five days in galactose culture did not increase the
uncoupled (that is, maximal) rate of oxygen consumption
(3.35 versus 3.51 μmol O2 consumption mL
−1 min−1 per
106 cells in glucose versus galactose media, respectively;
P = 0.40), suggesting that galactose culture did not in-
crease mitochondrial content. Consistent with this, we
found that 1 day of galactose culture did not increase
the expression of mitochondrial biogenesis transcription
factors TFAM and PGC1A (Figure 1 F). Furthermore,
after 5 days in galactose culture, the abundance of two
mitochondrial-associated proteins, ATP5B and VDAC1,
was not significantly altered (Figure 1G). However, the
average intensity of Mitotracker staining showed a trend
for an increase of approximately 50% between 1 and 5 days
of galactose culture (P = 0.052). In addition, protein levels
of succinate dehydrogenase (SDH), a Krebs cycle enzyme
and component of complex II of the MRC, increased after
5 days in galactose culture (P = 0.003; Figure 1H). Thus,
the increase in basal oxygen consumption after galactose
culture appears to be driven primarily by increased
mitochondrial oxygen consumption and electron trans-
port flux rather than increased mitochondrial content,
although specific mitochondrial proteins, such as SDH,
are increased.
We next assessed the metabolic redox and energy state
of chondrocytes by measuring the NAD+/NADH ratio
and the cellular energy charge, respectively. After 5 days
in galactose culture, the NAD+/NADH ratio was increased
by approximately 50% compared with glucose-cultured
cells, indicating a more oxidative cellular metabolic envir-
onment (P = 0.029; Figure 1I). To determine whether
5 days of galactose culture induced a sustained metabolic
stress, we measured AMP, ADP, and ATP to calculate the
energy charge for each culture condition. The cellular ad-
enylate energy charge is tightly regulated and usually
maintained at values between 0.88 and 0.92 [35,36]. After
5 days of galactose culture, the energy charge was reduced
Figure 1 Replacing glucose with galactose reduces glycolysis and upregulates mitochondrial respiration. (A) Cell viability was not altered
by 1 or 5 days of galactose culture (n = 6). Five days of galactose culture (B) significantly reduced lactate production (n = 6) and (C) trended
toward a decrease in lactate dehydrogenase (LDH) activity (n = 4), indicating a reduction in non-oxidative glycolytic flux. The reduction in glycolysis
after 5 days in galactose culture was offset by (D) an increase in the basal rate of cellular oxygen consumption (n = 6), which was associated with a
near maximal rate of oxygen consumption, as indicated by (E) the ratio of coupled to uncoupled respiration approaching 100 (n = 4). The increase in
mitochondrial respiration did not correspond to (F) an increase in the expression of genetic mediators of mitochondrial biogenesis (TFAM and PGC1A)
after 1 day of galactose culture (n = 4) or an (G) increased abundance of mitochondrial proteins (ATP5B and VDAC1) after 5 days in galactose
culture (n = 3). (H) However, 5 days of galactose culture significantly increased the expression of the mitochondrial electron transport chain and
Krebs cycle enzyme succinate dehydrogenase (SDH) (n = 4). These metabolic changes were not able to maintain cellular metabolic homeostasis
after 5 days of galactose culture, as indicated by (I) an increased ratio of NAD+ to NADH (n = 4) and (J) a decrease in the cellular energy charge
(n = 3). Bars represent mean ± standard error of the mean. *P <0.05 and **P <0.01 between glucose and galactose.
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versus 0.86 ± 0.02, glucose versus galactose; P = 0.048;
Figure 1 J). Thus, replacing glucose with galactose as a
carbohydrate source for 5 days induced a modest cellu-
lar energetic stress. Overall, these findings indicate that,
in response to a nutritional energetic stress, chondro-
cytes upregulate mitochondrial metabolic pathways in
an attempt to maintain energetic balance.
Effect of galactose culture on redox balance and
anti-oxidant function
We next investigated the effect of a shift toward increased
mitochondrial respiration on pro- and anti-oxidant path-
ways affecting chondrocyte redox balance. One of the pri-
mary ways that cells maintain redox balance is throughthe synthesis of glutathione. Reduced glutathione (GSH) is
a multi-faceted cellular anti-oxidant that directly reacts
with free radicals, serves as a cofactor for glutathione per-
oxidase, and reverses oxidative modifications by reducing
disulfide bonds [37]. Total glutathione levels remained
consistent between glucose and galactose culture condi-
tions (Figure 2A). In addition, the ratio of reduced to oxi-
dized glutathione (GSH/GSSG), an indicator of cellular
redox balance, was also consistent between day 5 glucose
and galactose conditions (Figure 2B). We next investigated
the basal production of nitric oxide by measuring the
levels of nitrite and nitrate (NOx) released into the media.
One day of galactose culture reduced NOx levels by 25%
(P = 0.053), and 5 days of galactose culture reduced NOx
release by 80% (P <0.001) compared with paired glucose
Figure 2 Galactose treatment downregulates nitric oxide production and the mitochondrial anti-oxidant SOD2 without altering oxidative
homeostasis. (A) Cell glutathione content was not altered by 1 or 5 days of galactose culture (n = 4). (B) glutathione redox homeostasis was
maintained after 5 days of galactose treatment (n = 4). (C) Five days of galactose culture significantly reduced nitrate and nitrite (NOx) release
into the culture media (n = 13). (D) Out of a panel of 12 cytosolic and mitochondrial anti-oxidant proteins, 5 days of galactose culture selectively
reduced the abundance of the mitochondrial SOD isoform, SOD2, as determined by selected reaction monitoring mass spectrometry (n = 3).
(E) Western blot analysis further verified the reduction in SOD2 abundance (n = 5). (F) Real-time polymerase chain reaction analysis showed a
significant reduction in gene expression of SOD2 (n = 5) but not the cytosolic SOD isoform, SOD1 (n = 4), after 5 days of galactose treatment.
(G) Five days of galactose treatment reduced the total activity of superoxide dismutase (tSOD) (n = 7). The reduction in tSOD activity after 5 days
in galactose culture was due primarily to a reduction in the activity of the mitochondrial SOD isoform, SOD2 (n = 7), (H) which paralleled the
reduction in SOD2 protein expression. Bars represent mean ± standard error of the mean. *P <0.05, **P <0.01, and ***P <0.001 between glucose
and galactose. Gal, galactose; Glu, glucose; GSH:GSSG, ratio of reduced to oxidized glutathione; SOD, superoxide dismutase.
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redox balance was unaffected by galactose, galactose-
stimulated mitochondrial respiration significantly reduced
the production of nitric oxide.
To further understand the effect of increased mito-
chondrial respiration on chondrocyte redox regulation,
we quantified the abundance of 12 cellular anti-oxidant
proteins by using SRM mass spectrometry after 5 days
of glucose or galactose culture (Figure 2D). This analysis
showed that stimulating mitochondrial respiration re-
duced the abundance of the mitochondrial isoform of
superoxide dismutase, SOD2, by 83% (P <0.0001). Galact-
ose treatment did not alter the abundance of any of the
other anti-oxidant proteins. We further verified the reduc-
tion in SOD2 protein levels by Western blot (Figure 2E)
and gene expression (Figure 2 F). We then examined the
effect of galactose culture on the total activity ofsuperoxide dismutase (tSOD) enzymes after 1 and 5 days
of galactose culture. One day in galactose culture did
not alter tSOD activity, and 5 days in galactose culture
showed a trend for a reduction in tSOD activity (P =
0.07; Figure 2G). When the activity of SOD2 was specif-
ically tested, we observed a 59% reduction in enzymatic
activity after 5 days in galactose culture (P = 0.026;
Figure 2H). Given that glutathione redox homeostasis
was retained in galactose culture despite the significant
reduction in SOD2 protein and activity, these findings
suggest that reduced SOD2 capacity is coupled to a re-
duction in superoxide (O2
●−) production. We tested this
prediction by using a cell-permeable chemical spin-trap
to quantify the rate of superoxide production by EPR
after 1 day of glucose or galactose culture (Figure 3A).
These results showed that 1 day of galactose culture
reduced the rate of superoxide production by 15%
Figure 3 Galactose-stimulated mitochondrial respiration reduces the rate of superoxide production. (A) Representative raw spectra
derived from electron paramagnetic resonance spectroscopy using the superoxide-specific cyclic hydroxylamine spin trap CMH (1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine). The comparison of spectra from cells cultured with glucose or galactose for 1 day shows a
reduction in spectral signal strength with galactose treatment, which is proportional to the rate of trapped superoxide. (B) The average rate of
superoxide generation was significantly reduced after 1 day of galactose culture compared with pair-matched glucose-cultured samples (n = 4).
AU, arbitrary units.
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chondrial respiration reduced the rate of cellular super-
oxide production as well as the expression of the
mitochondrial anti-oxidant enzyme SOD2.
Galactose-induced mitochondrial respiration
downregulates hypoxia-inducible factor 2α and its
target genes
To better understand how a nutrient-induced shift toward
mitochondrial respiration downregulates SOD2 expres-
sion, we investigated the expression of the transcription
factor HIF-2α. HIF-2α regulates the transcription of genes
that coordinate cellular metabolic and anti-oxidant re-
sponses during development and in response to metabolic
and oxidative stresses, including SOD2 [38]. After 1 day in
culture with CoCl2, which stabilizes HIF-2α [31], we de-
tected the nuclear expression of HIF-2α in both glucose-
and galactose-fed cells (Figure 4A). However, after 5 days
in galactose culture, HIF-2α nuclear expression was sig-
nificantly reduced (Figure 4A). Gene expression of
EPAS1, the gene that encodes HIF-2α, was also signifi-
cantly downregulated after 5 days of galactose culture
(Figure 4B). HIF-1α gene expression, however, was un-
changed after 5 days of galactose culture (P = 0.64;
Figure 4B).
HIF-2α transcriptionally regulates the expression of a
number of pro-inflammatory and catabolic genes in
chondrocytes, including NOS2, PTGS2, MMP13, and
ADAMTS4 [39,40]. After 5 days of galactose culture,
the expression of NOS2, PTGS2, and MMP13 was sig-
nificantly reduced (Figure 4C), consistent with the
downregulation in HIF-2α. ADAMTS4 was detected in
only two samples, although the fold reduction in ex-
pression relative to glucose was substantial in both
samples (0.15 and 0.07). The expression of cartilage
extracellular matrix proteins COL2A1 and ACAN wasnot significantly altered with galactose culture; how-
ever, similar to the catabolic genes, COL2A1 mRNA
expression trended lower (Figure 4C). We also exam-
ined the expression of the anti-oxidant enzyme catalase
(CAT), whose activity is significantly reduced in chon-
drocytes after HIF-2α small interfering RNA (siRNA)
treatment [41]. In the current study, galactose-induced
downregulation of HIF-2α was not associated with a re-
duction in CAT expression.
We subsequently investigated how stabilizing HIF-2α
affected the galactose-induced changes in redox and meta-
bolic coupling. CoCl2 was added to the culture media
24 hours prior to harvesting cells cultured for 1 or 5 days
in galactose- or glucose-supplemented media. After 1 day
in galactose media, SOD2 expression decreased by 43%
compared with the glucose controls (Figure 5A). CoCl2
treatment blocked this reduction in SOD2 levels in
galactose-cultured cells (P = 0.028) without altering those
in glucose-supplemented media (P = 0.55). After 5 days in
galactose media, SOD2 expression was not altered by
CoCl2 treatment (Figure 5A). These data suggest that
HIF-2α stabilization is sufficient to regulate the acute
(1 day), but not the sustained (5 day), downregulation in
SOD2 expression that occurs in response to upregulated
mitochondrial respiration. We examined the effect of
CoCl2 treatment on SDH expression to evaluate how sta-
bilizing HIF-2α alters metabolic coupling. Unlike the ef-
fects on SOD2 expression, CoCl2 treatment primarily
reduced the expression of SDH after 1 day of glucose cul-
ture, with a trend for reduced expression with galactose
culture as well (Figure 4B). These findings suggest that
HIF-2α is a negative regulator of SDH expression inde-
pendent of galactose treatment. Interestingly, we observed
that the effect of CoCl2 treatment on cell viability was
reduced in chondrocytes cultured with galactose for
1 day but not 5 days (1-day viability: 93.7% ± 1.8% versus
Figure 4 Galactose-induced mitochondrial respiration reduces hypoxia-inducible factor 2α (HIF-2α) expression and signaling. (A) Nuclear
expression of HIF-2α expression was evaluated after 1 or 5 days of glucose versus galactose treatment. Twenty-four hours of cobalt chloride (CoCl2)
treatment stabilized HIF-2α. Five days of galactose treatment dramatically reduced the nuclear expression of HIF-2α in CoCl2-stabilized samples
(n = 3). (B) Five days of galactose treatment also reduced the expression of EPAS1, the gene that encodes HIF-2α, but not HIF1 (n = 5). (C) The
expression of multiple HIF-2α target genes, including NOS2, PTGS2, and MMP13, was also reduced after 5 days of a galactose culture. Results
from galactose-treated chondrocytes were normalized to those from glucose samples to represent the fold induction in response to galactose.
Bars represent mean ± standard error of the mean. *P <0.05, **P <0.01, and ***P <0.001 between glucose and galactose.
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viability: 97.3% ± 0.4% versus 95.6% ± 1.1%; − CoCl2 ver-
sus + CoCl2; P = 0.053; Figure 5C). CoCl2 treatment did
not alter cell viability in glucose culture at day 1 but caused
a slight, albeit significant, reduction at day 5 (97.9% ± 0.7%
versus 96.1% ± 1.0%; − CoCl2 versus + CoCl2; P = 0.025;
Figure 5C). Thus, stabilizing HIF-2α expression reduces
cell viability, and the greatest effect is observed during an
acute increase in mitochondrial respiration.
Discussion
Chondrocytes rely primarily on non-oxidative glycolysis
to generate ATP for cellular energy [8,10,11]. Yet under
conditions of glucose deprivation or glycolysis inhibition,
chondrocytes increase oxygen consumption as a com-
pensatory response to maintain ATP production via the
MRC (that is, ‘the Crabtree effect’) [9,42]. The ability of
chondrocytes to respond to changes in substrate avail-
ability by altering their reliance on glycolysis versus oxi-
dative phosphorylation for ATP production is critical for
cell survival and for maintaining extracellular matrix
production [43,44]. However, the effect of this metabolic
flexibility on other cellular functions, such as cellular
oxidation and anti-oxidant defense pathways, is not well
understood in chondrocytes.
In this study, we tested the ability of primary bovine
chondrocytes to use oxidative phosphorylation to generateATP and maintain cell viability using a nutrient trigger to
upregulate mitochondrial respiration in mammalian cells.
This trigger—galactose—induced a metabolic stress in
chondrocytes, as indicated by a modest reduction in the
cellular energy charge and an increase in the ratio of
NAD+ to NADH. In response to this stress, chondro-
cytes increased their rate of oxygen consumption and
upregulated the mitochondrial respiratory chain and
Krebs cycle enzyme SDH. The increase in mitochondrial
respiration did not alter the cellular redox balance, as
indicated by a stable ratio of reduced to oxidized gluta-
thione. However, galactose treatment did substantially
reduce the production of nitric oxide, consistent with a
negative relationship between mitochondrial respiration
and nitric oxide production in chondrocytes [16,18,45].
Galactose treatment also significantly reduced the gen-
eration of superoxide (O2
●−), a reactive molecule rapidly
converted to hydrogen peroxide by the anti-oxidant en-
zyme superoxide dismutase (SOD). We found that the
mitochondrial isoform of SOD, SOD2, was selectively
reduced after galactose treatment. These findings show
that stimulating chondrocyte mitochondrial respiration
has a profound impact on the production and consump-
tion of cellular ROS, which results in the maintenance
of redox homeostasis.
The ability of a mitochondrial metabolic stimulus to
induce substantial changes in SOD2 expression has
Figure 5 Stabilization of hypoxia-inducible factor 2α (HIF-2α) impairs acute galactose-induced redox coupling and cell viability.
Chondrocytes were cultured in glucose- or galactose-supplemented media for 1 or 5 days and were treated with cobalt chloride (CoCl2) for the
final 24 hours to evaluate the effect of acute stabilization of HIF-2α. (A) CoCl2-mediated HIF-2α stabilization after 1 day of culture prevented the
galactose-induced reduction in superoxide dismutase 2 (SOD2) expression but had no effect on expression at 5 days or in any glucose culture
condition (n = 3). (B) CoCl2 treatment reduced succinate dehydrogenase (SDH) expression in 1-day glucose cultured cells and showed a trend for
reduced expression in galactose-treated samples at 1 and 5 days. Notably, CoCl2 treatment prevented the upregulation in SDH expression after
5 days of galactose culture (n = 3). (C) HIF-2α stabilization reduced cell viability in galactose- but not glucose-treated chondrocytes during the
acute (1 day) response to galactose (n = 3). After 5 days in glucose or galactose culture, HIF-2α stabilization modestly reduced cell viability in
glucose-treated cells, with a trend for reduced viability after galactose treatment (n = 6). Bars represent mean ± standard error of the mean.
*P <0.05 between +/− CoCl2 treatment.
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cartilage oxidative stress that occurs with aging and the
development of OA. Several laboratories have reported
that SOD2 expression is reduced in OA cartilage [8,19-21].
Gavriilidis and colleagues recently evaluated the association
between a reduction in SOD2 expression and an in-
crease in cartilage oxidation by depleting SOD2 inhuman articular chondrocytes using RNA interference
[8]. They found that a loss of SOD2 induced lipid perox-
idation and mitochondrial DNA strand breaks, verifying
an inverse link between SOD2 levels and chondrocyte
oxidation. Intriguingly, they also found that SOD2 de-
pletion reduced the spare respiratory capacity and in-
creased mitochondrial ATP turnover. Thus, the findings
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ship between mitochondrial respiration and SOD2 ex-
pression in chondrocytes.
This raises important questions about the extent to
which metabolic stress signals contribute to OA risk by
coupling the downregulation of SOD2 with increased
mitochondrial respiration. OA cartilage is characterized
by a reduction in the expression of several glycolytic
enzymes and increased mitochondrial respiration under
basal conditions [8,46]. Our finding that a nutrient-
induced increase in mitochondrial respiration is coupled
to a significant reduction in SOD2 expression may make
chondrocytes more susceptible to oxidative damage. For
example, well-established risk factors for OA, such as
biomechanical trauma and increased levels of pro-
inflammatory cytokines, damage chondrocytes in part
by increasing the production of mitochondrial ROS
[47-50]. Under acute stress, chondrocytes upregulate
SOD2 expression to counteract increased ROS production
via nuclear factor-kappa-B (NF-κB) signaling, which is the
primary stress-responsive transcription factor regulating
SOD2 expression [51,52]. Metabolic stress sensors, such
as AMP-activated protein kinase (AMPK) [53] and sir-
tuins [54], are potent anti-inflammatory mediators, in part
through inhibition of NF-κB signaling. Thus, it is not clear
whether the downregulation of SOD2 resulting from a
nutrient stress makes chondrocytes more susceptible to
oxidative damage, because NF-κB activation can also
promote ROS production in a feed-forward manner.
Liu-Bryan and Terkeltaub recently reviewed the dual
roles of AMPK and SIRT1 in linking cellular bioener-
getic sensing to the regulation of transcriptional ‘go
signals’ (for example, NF-κB, HIF-2α, and MTF1) that
initiate pro-inflammatory chondrocyte reprogramming
[55]. In chondrocytes, activation of AMPK and SIRT1
attenuates the catabolic response to pro-inflammatory
and biomechanical stressors [56-59]. In our study, sus-
tained galactose feeding for 5 days would be expected to
activate AMPK because of the reduction in cellular en-
ergy charge. Similarly, the increased ratio of NAD+ to
NADH would be expected to drive the expression and
activation of SIRT1. Consistent with an expected reduc-
tion in pro-inflammatory mediators, the expression of
NOS2 and PTGS2 was significantly reduced after galactose
culture. Our results suggest that a key pro-inflammatory
‘go signal’ that is downregulated in response to a nutrient
stress is HIF-2α.
HIF-2α is a redox-sensitive and stress-responsive tran-
scription factor. It transactivates multiple gene targets
involved in cellular anti-oxidant defense, including SOD2
[38], and is also a central regulator of endochondral ossifi-
cation and articular cartilage matrix homeostasis [39,40,60].
HIF-2α positively regulates the expression of genes that
mediate chondrocyte hypertrophy, such as COL10A1,MMP13, and VEGFA. These actions of HIF-2α are reca-
pitulated during the pathogenesis of OA, where HIF-2α
promotes cartilage catabolism by upregulating the expres-
sion of pro-inflammatory and pro-hypertrophic genes in
articular cartilage [39,40]. Although the stability of HIF-2α
protein expression is regulated by oxygen-dependent
hydroxylases, the activity of HIF-2α is regulated by post-
translational reversible protein acetylation [61]. This sug-
gests that HIF-2α is well suited to coordinate changes in
cellular metabolic and redox status. Indeed, Bohensky and
colleagues previously reported that silencing HIF-2α stim-
ulated ROS production and activated a robust autophagic
response [41]. Our findings show that stabilizing HIF-2α
during an acute nutrient stress causes cell death, possibly
by disrupting a pro-survival autophagic response. How-
ever, after 5 days of galactose-stimulated mitochondrial
respiration, CoCl2 treatment did not reduce cell viabil-
ity. This may be due to the downregulation in EPAS1
expression, which could diminish the effectiveness of
CoCl2 to activate HIF-2α-mediated signaling.
Our study provides the first observation that HIF-2α
expression is negatively associated with increased mito-
chondrial metabolism in chondrocytes. This observation
is important because it suggests that changes in cellular
metabolism may directly mediate HIF-2α signaling. Ele-
vated succinate levels promote HIFα stabilization by
impairing oxygen-dependent prolyl hydroxylase activity,
which targets HIFα for degradation [62,63]. In our study,
galactose treatment significantly increased SDH expression
in chondrocytes. An increase in the utilization of succinate
to generate reducing equivalents for mitochondrial respir-
ation would be expected to decrease succinate-mediated
inhibition of prolyl hydroxylase activity, thereby promoting
HIF-2α degradation. We also observed a decrease in
EPAS1 gene expression with galactose culture, indicat-
ing that stimulating mitochondrial respiration downre-
gulates HIF-2α through additional genetic mechanisms.
Our findings build on recently reviewed work [55]
suggesting that manipulating cellular metabolic stress re-
sponses may provide an integrative therapeutic approach
to modify cartilage inflammation and degradation. Key
questions remain, however, about how to implement
such therapies and which molecules or pathways to spe-
cifically target. For example, it is not known whether a
systemic metabolic stress, as occurs with weight loss or
caloric restriction, is sufficient to induce a metabolic stress
response in articular cartilage. Lifelong caloric restriction
does not alter age-associated knee OA in 24-month old
mice, but it does delay the development of hip OA in dogs
[64,65]. Furthermore, our study suggests that downregula-
tion of HIF-2α contributes to the anti-catabolic effects of
a nutrient metabolic stress. However, sustained inhibition
of HIF-2α may be deleterious as it also promotes cartilage
anabolism [66]. Implementing metabolic-based therapies
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the dynamic in vivo changes that occur in chondrocyte
metabolic signaling and energetic flux during normal and
pathologic conditions. Such knowledge may also lead to a
better understanding of OA risk factors, such as with
obesity-associated metabolic disease clustering and mito-
chondrial DNA haplogroup variants [67,68].
Conclusions
Our findings show that chondrocyte metabolic flexibility
promotes cell survival during periods of limited nutrient
availability by upregulating mitochondrial respiration.
The increase in mitochondrial metabolism is coupled to
a substantial reduction in the expression and activity of
the mitochondrial anti-oxidant SOD2 and its pro-catabolic
transcription factor HIF-2α. Both SOD2 and HIF-2α
undergo differential expression during the development of
OA, initially being upregulated after acute inflammation
and subsequently downregulated with disease progression
[21,39-41,51]. Thus, an improved understanding of chon-
drocyte metabolism during OA pathogenesis may lead to
new insight into the etiology of OA and the development
of metabolic-based therapeutic targets.
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